Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently bought shares of Becton, Dickinson and Company NYSE: BDX. In a filing disclosed on June 09th, the Representative disclosed that they had bought between $1,001 and $15,000 in Becton, Dickinson and Company stock on May 15th. The trade occurred in the Representative's "JP MORGAN BROKERAGE ACCOUNT" account.
Representative Robert Bresnahan, Jr. also recently made the following trade(s):
- Sold $1,001 - $15,000 in shares of Zoom Communications NASDAQ: ZM on 6/25/2025.
- Purchased $1,001 - $15,000 in shares of Coinbase Global NASDAQ: COIN on 6/24/2025.
- Purchased $1,001 - $15,000 in shares of Circle Internet Group NYSE: CRCL on 6/24/2025.
- Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 6/23/2025.
- Sold $1,001 - $15,000 in shares of Chubb NYSE: CB on 6/13/2025.
- Sold $1,001 - $15,000 in shares of Atlassian NASDAQ: TEAM on 6/11/2025.
- Purchased $1,001 - $15,000 in shares of ServiceTitan NASDAQ: TTAN on 6/11/2025.
- Sold $1,001 - $15,000 in shares of Datadog NASDAQ: DDOG on 6/11/2025.
- Sold $1,001 - $15,000 in shares of GitLab NASDAQ: GTLB on 6/11/2025.
- Purchased $1,001 - $15,000 in shares of Broadcom NASDAQ: AVGO on 6/11/2025.
Becton, Dickinson and Company Trading Up 1.0%
Shares of BDX stock traded up $1.89 during trading hours on Friday, hitting $185.52. 1,875,850 shares of the company were exchanged, compared to its average volume of 2,931,804. The firm has a market cap of $53.17 billion, a P/E ratio of 35.40, a P/E/G ratio of 1.39 and a beta of 0.25. Becton, Dickinson and Company has a fifty-two week low of $163.33 and a fifty-two week high of $251.99. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.64 and a current ratio of 1.13. The company has a 50 day simple moving average of $174.31 and a two-hundred day simple moving average of $202.75.
Becton, Dickinson and Company (NYSE:BDX - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $3.35 EPS for the quarter, topping the consensus estimate of $3.28 by $0.07. Becton, Dickinson and Company had a net margin of 7.28% and a return on equity of 15.99%. The company had revenue of $5.27 billion during the quarter, compared to the consensus estimate of $5.35 billion. During the same quarter last year, the firm posted $3.17 EPS. The company's quarterly revenue was up 4.5% on a year-over-year basis. Equities analysts anticipate that Becton, Dickinson and Company will post 14.43 EPS for the current year.
Becton, Dickinson and Company Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Monday, September 8th will be issued a $1.04 dividend. This represents a $4.16 annualized dividend and a yield of 2.24%. The ex-dividend date is Monday, September 8th. Becton, Dickinson and Company's payout ratio is presently 79.39%.
Wall Street Analyst Weigh In
A number of brokerages recently commented on BDX. Barclays decreased their target price on Becton, Dickinson and Company from $261.00 to $241.00 and set an "overweight" rating for the company in a research report on Tuesday, June 3rd. Stifel Nicolaus cut their target price on Becton, Dickinson and Company from $280.00 to $224.00 and set a "buy" rating on the stock in a report on Friday, May 2nd. William Blair cut Becton, Dickinson and Company from an "outperform" rating to a "market perform" rating in a report on Thursday, May 1st. Bank of America cut Becton, Dickinson and Company from a "buy" rating to a "neutral" rating and set a $190.00 target price on the stock. in a report on Thursday, May 1st. Finally, Wall Street Zen cut Becton, Dickinson and Company from a "buy" rating to a "hold" rating in a report on Friday, May 2nd. Eight investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $219.22.
View Our Latest Analysis on BDX
Insider Activity
In other Becton, Dickinson and Company news, EVP Michael David Garrison sold 1,185 shares of the firm's stock in a transaction dated Friday, July 18th. The stock was sold at an average price of $180.29, for a total value of $213,643.65. Following the completion of the transaction, the executive vice president owned 4,887 shares in the company, valued at $881,077.23. This trade represents a 19.52% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP David Shan sold 1,166 shares of the firm's stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $171.19, for a total value of $199,607.54. Following the completion of the transaction, the executive vice president owned 4,575 shares of the company's stock, valued at approximately $783,194.25. This represents a 20.31% decrease in their position. The disclosure for this sale can be found here. 0.36% of the stock is owned by company insiders.
Institutional Investors Weigh In On Becton, Dickinson and Company
Large investors have recently made changes to their positions in the business. Bank of Jackson Hole Trust bought a new position in shares of Becton, Dickinson and Company during the 4th quarter worth $25,000. Saudi Central Bank bought a new position in shares of Becton, Dickinson and Company during the 1st quarter worth $26,000. Smallwood Wealth Investment Management LLC bought a new position in shares of Becton, Dickinson and Company during the 1st quarter worth $27,000. Sierra Ocean LLC bought a new position in shares of Becton, Dickinson and Company during the 4th quarter worth $29,000. Finally, REAP Financial Group LLC grew its stake in shares of Becton, Dickinson and Company by 75.3% during the 4th quarter. REAP Financial Group LLC now owns 128 shares of the medical instruments supplier's stock worth $29,000 after acquiring an additional 55 shares during the period. 86.97% of the stock is owned by hedge funds and other institutional investors.
About Representative Bresnahan
Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania's 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania's 8th Congressional District. He declared candidacy for the 2026 election.
Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.
About Becton, Dickinson and Company
(
Get Free Report)
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.
Featured Articles
Before you consider Becton, Dickinson and Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Becton, Dickinson and Company wasn't on the list.
While Becton, Dickinson and Company currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
